Inside a Personalized Plan
What goes into a personalized regenerative treatment strategy, from the first review of records to the research behind digestive, autoimmune joint and spinal care.
- Stem Cells
- 2 min
08/04/2026
Starting With the Details
A treatment strategy is only as good as the information behind it. Before any plan is drawn up, a physician needs a clear view of the patient’s condition and history. In regenerative medicine, where therapies work alongside the body’s own healing mechanisms, that view matters even more. Our physicians usually look at:
- The diagnosis and how long the condition has been present
- Treatments already tried and how the patient responded
- Recent imaging, lab results and specialist reports
- Other health conditions and current medication
- What the patient most wants to improve in daily life
What the Research Covers
Three fields come up often. In inflammatory bowel disorders, scientists are studying how specialized cells may help create a healthier environment for damaged intestinal tissue. In autoimmune joint conditions, clinical studies look at joint function and mobility over time. For persistent spinal discomfort, minimally invasive approaches are being investigated as a way to support tissue repair.
Each of these areas is still developing, and the results reported vary between patients.
Turning Information Into a Plan
With the details and the research side by side, the physician can explain whether cell therapy is appropriate. Sometimes the answer is yes. Sometimes another route makes more sense, and the patient leaves with that advice.
When treatment is recommended at Regeneration Clinic Panama, it uses mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory.
Adjusting Over Time
A strategy is reviewed as the patient progresses. Check-ins at 1, 3, 6, 9 and 12 months after treatment allow our team to see how each person is responding and to keep their home physician informed.
08/04/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






